Does GEFITINIB Cause Metastasis? 68 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Metastasis have been filed in association with GEFITINIB (Gefitinib). This represents 1.5% of all adverse event reports for GEFITINIB.
68
Reports of Metastasis with GEFITINIB
1.5%
of all GEFITINIB reports
18
Deaths
12
Hospitalizations
How Dangerous Is Metastasis From GEFITINIB?
Of the 68 reports, 18 (26.5%) resulted in death, 12 (17.6%) required hospitalization, and 2 (2.9%) were considered life-threatening.
Is Metastasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEFITINIB. However, 68 reports have been filed with the FAERS database.
What Other Side Effects Does GEFITINIB Cause?
Malignant neoplasm progression (1,651)
Drug resistance (1,228)
Death (590)
Diarrhoea (393)
Rash (318)
Metastases to central nervous system (306)
Acquired gene mutation (250)
Disease progression (244)
Drug ineffective (197)
Off label use (166)
What Other Drugs Cause Metastasis?
RIBOCICLIB (404)
LETROZOLE (284)
TRASTUZUMAB (273)
CYCLOPHOSPHAMIDE (267)
FULVESTRANT (262)
CAPECITABINE (233)
BEVACIZUMAB (225)
CARBOPLATIN (206)
LEUPROLIDE (201)
PACLITAXEL (198)
Which GEFITINIB Alternatives Have Lower Metastasis Risk?
GEFITINIB vs GELATIN
GEFITINIB vs GEMCITABINE
GEFITINIB vs GEMCITABINE\GEMCITABINE
GEFITINIB vs GEMFIBROZIL
GEFITINIB vs GEMTUZUMAB OZOGAMICIN